Khiron Life Sciences Reports 2018 Fiscal Year End Results and Provides Corporate Update
Secured approximately $40 million of investment capital for cultivation site construction, product development and distribution
Became the first Colombian cannabis company to list on the TSX Venture Exchange
Geographic footprint to countries including Colombia, Mexico, Chile, Peru, Uruguay and Italy
Received first INVIMA approvals for seven CBD-based cosmeceutical products in Colombia.
Generated first revenue in Q4 2018 with the commercialization of the Kuida® brand of cosmeceutical products
Increased potential cultivation capacity to 220 tonnes per annum through organic growth and pending acquisitions
Made key management and board appointments including Mr. Vicente Fox as Director of the Board, the former CEO of Coca Cola Mexico and former President of Mexico
Net working capital position of $17,493,835
Raised $28,842,000 in bought deal financing including full exercise of over-allotment option, subsequent to the quarter